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The spread of pandemic Staphylococcus aureus clones, mainly methicillin-resistant S. aureus
(MRSA), must be kept under surveillance to assemble an accurate, local epidemiological
analysis. In Ecuador, the prevalence of the USA300 Latin American variant clone (USA300-
LV)  is well known; however, there is little information about other circulating clones. The
aim  of this work was to identify the sequence types (ST) using a Multiple-Locus Variable
number tandem repeat Analysis 14-locus genotyping approach. We  analyzed 132 S. aureus
strains that were recovered from 2005 to 2013 and isolated in several clinical settings in Quito,
Ecuador. MRSA isolates composed 46.97% (62/132) of the study population. Within MRSA, 37
isolates were related to the USA300-LV clone (ST8-MRSA-IV, Panton-Valentine Leukocidin
[PVL] +) and 10 were related to the Brazilian clone (ST239-MRSA-III, PVL−). Additionally, two
isolates (ST5-MRSA-II, PVL−) were related to the New York/Japan clone. One isolate was
related to the Pediatric clone (ST5-MRSA-IV, PVL−), one isolate (ST45-MRSA-II, PVL−) was
related to the USA600 clone, and one (ST22-MRSA-IV, PVL−) was related to the epidemic UK-
EMRSA-15 clone. Moreover, the most prevalent MSSA sequence types were ST8 (11 isolates),
ST45 (8 isolates), ST30 (8 isolates), ST5 (7 isolates) and ST22 (6 isolates). Additionally, we
found one isolate that was related to the livestock associated S. aureus clone ST398. We
conclude that in addition to the high prevalence of clone LV-ST8-MRSA-IV, other epidemic
clones are circulating in Quito, such as the Brazilian, Pediatric and New York/Japan clones.
The  USA600 and UK-EMRSA-15 clones, which were not previously described in Ecuador,
were also found. Moreover, we found evidence of the presence of the livestock associatedclone  ST398 in a hospital environment.
©  2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. This is an
open  access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
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Introduction
Staphylococcus aureus is one of the most prevalent human
pathogens causing a wide range of infectious diseases. Since
the introduction of methicillin as a therapeutic option, the
emergence and subsequent spread of MRSA has become a
worldwide concern. The acquisition of the staphylococcal cas-
sette chromosome mec  (SCCmec), which includes the gene
mecA of methicillin resistance, was the primary event lead-
ing to the appearance of MRSA isolates.1–3 Evidence suggests
that this event occurred several times around the world, in
different genetic backgrounds, leading to the wide biodiver-
sity of S. aureus strains. Some of these clones are predominant
in speciﬁc geographic regions, while others have become
pandemics.4,5 Three groups of MRSA isolates can be rec-
ognized: hospital associated MRSA (HA-MRSA), community
associated MRSA (CA-MRSA), and livestock associated MRSA
(LA-MRSA) strains.6 Moreover, the epidemiological behavior of
methicillin-susceptible S. aureus (MSSA) remains an important
area of study in clinical settings around the world.5
First reported in the 1960s, MRSA strains were initially con-
ﬁned to the hospital environment.6 HA-MRSA encompasses
diverse epidemic and pandemic clones, which vary with geog-
raphy. For instance in the USA, the most prevalent HA-MRSA
clones are ST5-MRSA-II (USA100/NY-Japan) and ST5-MRSA-
IV (USA800/Pediatric), while in the UK the most prevalent
HA-MRSA clone is the ST22-MRSA-IV (UK-EMRSA-15) clone.
In South America, the most disseminated HA-MRSA clone
is the ST239-MRSA-III (Brazilian Epidemic Clone [BEC]).3,7–9
Even though, the Cordobes/Chilean (ST5-MRSA-I) clone was
found as the most prevalent in countries like Chile and
Argentina.3,8–10 The ST5-MRSA-II and a variant of the ST239-
MRSA-III are the most prevalent clones in Asia.8
In the1990s, infections with MRSA strains in patients with-
out risk factors began to be reported.11 These CA-MRSA
strains had emerged almost simultaneously around the world,
by independent events of SCCmec acquisition, constituting
different epidemic clones.12 In Europe for instance, the ST80-
MRSA-IV strains (European clone) are widely spread, and in
East Asia the ST59-MRSA-IV clone remains common.13,14 In
North America, the most prevalent is the epidemic USA300
clone (ST8-MRSA-IV), which has extensively replaced previous
clones, such as USA100 and other HA-MRSA clones, mainly
in USA.11,15 The USA300 clone is actually considered pan-
demic, as it has been isolated repeatedly in every continent.12
Recently, a Latin American native CA-MRSA clone, closely
related to the pandemic USA300, was described as preva-
lent in the northern South America region, in both hospital
settings and community environments.16 This ST8-MRSA-IV
clone, USA300-LV, has been found to carry Panton Valentine
Leukocidin (PVL) haplotype R.17 Since it was ﬁrst reported
in 2006, studies have demonstrated that this clone has fully
replaced the previously established Chilean/Cordobes clone in
northern South America.18
Another group of S. aureus,  the livestock associated S.
aureus, has become a worldwide threat associated with the
handling of farm animals.19 The main clone associated with
livestock includes strains belonging to the ST398 lineage,
and both MRSA and MSSA strains.20,21 Since its primary 1 6;2  0(6):525–533
identiﬁcation in the Netherlands in 2003 in domestic pigs, this
clone has been reported in most of European countries, North
America and Asia, not only in pigs but also in cattle, horses,
poultry, and humans.6,20 Initially, the carriage and infection of
these strains were associated with direct contact with animal
farming as the major risk factor. Currently, increasing reports
describe invasive infections with ST398 in patients with no
previous livestock environment contact.22
There is little information about the clones of either HA-
MRSA or CA-MRSA circulating in Ecuador. In a regional,
multicenter study in 2009, we  described the clones estab-
lished in Colombia, Venezuela, Peru, and Ecuador.16 The study
focused on CA-MRSA strains, and it provided evidence of the
extensive presence of the USA300-LV clone in Ecuador. More-
over, we identiﬁed a signiﬁcant presence of the HA-MRSA
Brazilian Epidemic Clone.
There are various genotyping methods available to study
the epidemiology of S. aureus,  each one with different
advantages and disadvantages, as well as different resolving
power.8 Multiple-Locus Variable number tandem repeat Anal-
ysis (MLVA) represents a high-throughput genotyping method
characterized by its low cost and high resolution.23,24 To iden-
tify the clones of S. aureus circulating in Ecuador, we applied
an MLVA typing approach to a heterogeneous strain collection
including both MRSA and MSSA isolates.
Methods
Bacterial  study  population  and  antimicrobial  susceptibility
proﬁle
A total of 132 S. aureus isolates, from different populations,
were studied. One set (population 1, P1) consisted of 80 isolates
consecutively recovered between 2010 and 2013 from blood-
stream infections of patients from three hospitals in Quito,
Ecuador. Another set (population 2, P2) contained 32 non-
consecutive isolates recovered between 2011 and 2013 from
different clinical infections from 11 different clinical settings.
Lastly, a third set (population 3, P3) consisted of 20 isolates
recovered from different clinical origins between 2005 and
2007. These isolates were randomly selected from a MRSA
archived collection belonging to a hospital in Quito. The pur-
pose of analyzing different sets of isolates was to detect a
wider variety of local clones other than USA-300-LV.
Antimicrobial susceptibility proﬁling was performed on
all isolates. Minimum inhibitory concentrations (MICs) were
obtained for oxacillin, gentamicin, ciproﬂoxacin, eryth-
romycin, clindamycin, linezolid, vancomycin, tetracycline,
tigecycline, rifampicin, and trimethoprim-sulfamethoxazole
using the Vitek®2 System, according to manufacturer speci-
ﬁcations and CLSI delineations. Additionally, we  have tested
the susceptibility to cefoxitin (data not shown), in order to rule
out the presence of mecC.25
Detection  of  mecA  and  Panton-Valentine  Leukocidin  (PVL)
virulence  factorsThe presence of the gene mecA, and the lukS-PV and lukF-PV
genes, encoding the subunits of PVL, were detected using a
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CR-multiplex with speciﬁc primers described elsewhere.26,27
dditionally, the PCR-multiplex ampliﬁed the S. aureus species
peciﬁc gene nuc.28 Brieﬂy, one reaction mix  contained 5 ng of
NA, 12.5 L of GoTaq® Green Master Mix  (1×  Green GoTaq®
eaction Buffer [pH 8.5], 200 M of each dNTP and 1.5 mM
gCl2, Promega) and 0.4 M of each primer in a ﬁnal volume of
5 L. The PCR program included 35 cycles of 30 s of denatur-
tion at 94 ◦C, 30 s of annealing at 62 ◦C and 1 min  of extension
t 72 ◦C. The PCR products of PVL were sequenced in selected
solates to identify the haplotype.29
creening  for  the  SCCmec  type
e  carried out the SCCmec typing using the Chen, et al.
2009) scheme, with modiﬁcations. Conventional single PCR
as performed using primers speciﬁc to genes of mec and ccr
omplexes.30 The PCR reactions contained 5 ng of DNA, 12.5 L
f GoTaq® Green Master Mix  and 0.4 M of each primer in a
nal volume of 25 L. The PCR program included 35 cycles of
0 s of denaturation at 95 ◦C, 30 s of annealing at 55 ◦C and 30 s
f extension at 70 ◦C. The PCR products were visualized in 3%
ltraPureTM Agarose-1000 electrophoresis gels (Promega).
ultiple-Locus  Variable  number  of  tandem  repeat
nalysis  (MLVA)  typing
e  used speciﬁc primers to independently amplify a 14 VNTR
anel known as MLVA 14Orsay.23,31 PCR reactions were per-
ormed in 25 L reactions containing 5 ng of DNA, 12.5 L of
oTaq® Green Master Mix  and 0.2 M of each primer. The PCR
rogram consisted of 25 cycles of denaturation at 94 ◦C for
0 s, annealing at 60 ◦C for 30 s and extension at 72 ◦C for 30 s.
he PCR products were resolved in 2% agarose electrophore-
is gels. The exact copy number of the repetitive unit in each
ocus was calculated as previously described.23 Four strains
ith a previously known copy number of repetitive units in
ach VNTR were use as controls and were included in every
un. The sequence type of the four MLVA control strains are
T5, ST8, ST30, and ST45, which were conﬁrmed by MLST as
escribed elsewhere.32 We identiﬁed the ST related to the 132
solates by querying the MLVA genotypes of each isolate in the
LVAbank for Bacterial Genotyping (http://mlva.u-psud.fr/ [S.
ureus database]). Simpson’s diversity index was applied.33 A
PGMA dendrogram was constructed using the categorical
istance coefﬁcient, applying a cut-off of 45% similarity.23 A
inimum spanning tree (MST) was built using the PHYLOViZ
.1 software.
esults
solate  population  and  antimicrobial  proﬁle
he origin, sex and age of the patients from which the 132 iso-
ates were taken are summarized in Table 1. All isolates were
usceptible to vancomycin, linezolid, and tigecycline. Sixty-
wo (47%) isolates were MRSA. Of these, 74.1% were susceptible
o gentamicin, 69.3% to ciproﬂoxacin, 62.9% to erythromy-
in, 75.8% to clindamycin, 82.3% to tetracycline, 87.1% to
ifampicin, and 72.6% to trimethoprim-sulfamethoxazole. On6;2 0(6):525–533 527
the other hand, 70 (53%) isolates were MSSA. Of these,
94.3% were susceptible to gentamicin, 92.9% to ciproﬂoxacin,
61.4% to erythromycin, 85.7% to clindamycin, 87.1% to
tetracycline, 94.3% to rifampicin, and 100% to trimethoprim-
sulfamethoxazole (Table 2). All MRSA isolates were cefoxitin
resistant and all MSSA isolates were cefoxitin susceptible.
PVL  detection,  SCCmec  types,  sequence  types  and  clones
The presence of the mecA methicillin resistant gene was
detected in all isolates identiﬁed as MRSA using the Vitek®2
System (46.97%). The PVL virulence factor was detected in 56
isolates (42.42%): 67.86% of MRSA isolates and 32.14% of MSSA
isolates (Fig. 1). SCCmec type II was identiﬁed in ﬁve isolates,
SCCmec type III in 10 isolates, and SCCmec type IV was detected
in 45 isolates. The typing scheme failed to identify the SCCmec
type in two isolates. Querying the MLVA genotypes against the
MLVA bank for Bacterial Genotyping database we  identiﬁed
18 different sequence types (ST). Fifty-ﬁve isolates (41.67%; 44
MRSA and 11 MSSA) belonged to ST8. All of the ST8 MRSA
isolates presented the SCCmec type IV genotype, except one
cataloged as indeterminate. The ST8-MRSA-IV-PVL positive
proﬁle (USA300-LV related) was detected in 37 isolates. PVL
haplotype was analyzed in 16 USA300-LV related isolates and
all were identiﬁed as R. The ST8-MRSA-PVL negative proﬁle
was detected in six isolates, whereas ST8-MSSA-PVL positive
proﬁle was detected in nine isolates. Ten isolates were identi-
ﬁed as ST239, all of which presented the SCCmec type III and
were PVL negative (Brazilian Epidemic Clone related). Ten and
two isolates belonged to ST5 and ST105 (MLST Single Locus
Variant [SLV] of ST5), respectively. Three of the ST5 isolates
were MRSA; two of these were SCCmec type II, related to the
New York/Japan clone, and one isolate was SCCmec  type IV,
related to the Pediatric clone. The two ST105 isolates were
SCCmec type II. Only two ST5 MSSA strains were PVL posi-
tive. Other representative STs found here were ST45 and ST30
with nine isolates each. One ST45 isolate had the USA600 pro-
ﬁle (ST45-MRSA-II, PVL negative) and only one ST30 was MRSA
with an indeterminate SCCmec type. Seven isolates were ST22,
one of which had the UK-EMRSA-15 proﬁle (ST22-MRSA-IV,
PVL negative). Additionally, seven and six isolates were ST97
and ST121, respectively, all of them were MSSA. We  also iden-
tify one MSSA isolate related to the livestock associated ST398
clone. Four isolates could not be genotyped as a speciﬁc ST
(Fig. 1).
Genotyping  analysis  of  MRSA  and  MSSA  isolates
All 132 isolates were resolved into 118 MLVA genotypes with
an overall Simpson’s diversity index of 0.99. The 62 MRSA iso-
lates and the 70 MSSA isolates belonged to 50 and 69 MLVA
genotypes, respectively. From all MLVA genotypes, 12 clus-
ters were identiﬁed using a 45% cut-off value in a UPGMA
tree, which includes 127 (96.21%) isolates (Fig. 1). These clus-
ters were included among the major Clonal Complexes (CC)
identiﬁed in the MST analysis (Fig. 2). The largest cluster was
CC8, with 52 (39.39%) isolates, including 37 USA300-LV related
isolates. The clusters CC5, CC8 – ST239/241 and CC30 had
11 isolates each, including two New York/Japan related iso-
lates (CC5), one Pediatric related isolate (CC5) and 10 Brazilian
528  b r a z j i n f e c t d i s . 2 0 1 6;2  0(6):525–533
Table 1 – Patient characteristics from whom MRSA and MSSA have been recovered.
MRSA (%) MSSA (%) Total (%) Clonesa (no. isolates)
Gender
Male 44 (51.8%) 41 (48.2%) 85 (64.4%) USA300-LV (23)
Brazilian (9)
New York/Japan (2)
Pediatric (1)
USA600 (1)
ST398 (1)
Female 18 (38.3%) 29 (61.7%) 47 (35.6%) USA300-LV (14)
Brazilian (1)
UK-EMRSA-15 (1)
Age
Mean (y) 38.5 48.9 43.7
Age group
0–17 13 (68.42%) 6 (31.58%) 19 (14.39%) USA300-LV (8)
Pediatric (1)
18–50 22 (53.66%) 19 (46.34%) 41 (31.06%) USA300-LV (13)
Brazilian (6)
USA600 (1)
51–90 22 (40%) 33 (60%) 55 (41.67%) USA300-LV (14)
Brazilian (3)
New York/Japan (1)
UK-EMRSA-15 (1)
N.D. 5 (29.41%) 12 (70.59%) 17 (12.88%) USA300-LV (2)
Brazilian (1)
New York/Japan (1)
ST398 (1)
Site of infection
Skin and soft tissue 19 (82.61%) 4 (17.39%) 23 (17.42%) USA300-LV (13)
Brazilian (3)
Blood 27 (31.39%) 59 (68.60%) 86 (65.15%) USA300-LV (19)
Brazilian (1)
New York/Japan (2)
UK-EMRSA-15 (1)
USA600 (1)
ST398 (1)
Respiratory tract 5 (62.50%) 3 (37.50%) 8 (6.06%) USA300-LV (1)
Brazilian (1)
Pediatric (1)
Bone 4 (80%) 1 (20%) 5 (3.79%) USA300-LV (1)
Brazilian (3)
Others 7 (70%) 3 (30%) 10 (7.57%) USA300-LV (3)
Brazilian (2)a Clones identiﬁed in this study.
related isolates. The CC1 (two isolates), CC22 (seven isolates),
CC45 (nine isolates), CC97 (eight isolates), CC109 (two isolates),
and CC121 (six isolates) clusters accounted for 25.76% of the
studied collection, including one USA600 related isolate (CC45)
and one UK-MRSA-15 related isolate (CC22). One cluster had
a heterogeneous composition with isolates belonging to ST8
(four isolates), ST5 (one isolate), and an unspeciﬁed ST (one
isolate). Furthermore, one cluster was composed of two unspe-
ciﬁc STs. The remaining ﬁve isolates belonged to ST101, ST109,
ST25, ST15, and the livestock associated ST398.Discussion
Epidemic clones of S. aureus have successfully spread world-
wide. Some of these clones have reached high prevalenceat the local level (Cordobes/Chilean clone), and others have
become the most prevalent circulating clones at a regional
level (USA300, LA-MRSA ST398 or UK-MRSA-15 clones).8 In
Latin America, native clones such as the Brazilian, Cor-
dobes/Chilean and Pediatric clones, and “imported” clones
such as the New York/Japan and USA300 clones have been
described.9 In Ecuador, only two clones had been described;
the predominant USA300-LV clone, and the Brazilian clone,
which has lower prevalence.16,18 In this study we  identiﬁed
additional clones using the MLVA genotyping tool. This molec-
ular tool is a high-throughput typing method, characterized by
its low cost and high discriminatory power. MLVA has proven
to be a reliable typing method with high concordance with
other typing methods such as PFGE and MLST.16,23,24,34
We  found a high number of isolates related to the
USA300 clone (ST8-MRSA-IV, PVL positive), conﬁrming the
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Table 2 – Number of susceptible isolates according to the sequence type (ST).
ST MSSA
(no. of
isolates)
MRSA
(no. of
isolates)
Gentamicin Ciproﬂoxacin Erythromycin Clindamycin Tetracycline Rifampicin Trimethoprim-
sulfamethoxazole
MSSA MRSA MSSA MRSA MSSA MRSA MSSA MRSA MSSA MRSA MSSA MRSA MSSA MRSA
5 7 3 6 1 7 1 2 0 7 1 4 3 7 2 7 3
8 11 44 11 41 11 40 9 37 10 43 10 43 11 44 11 38
15 1 0 1 – 1 – 1 – 1 – 1 – 1 – 1 –
22 6 1 4 1 6 1 5 1 6 1 6 1 6 1 6 1
25 1 0 1 – 1 – 1 – 1 – 1 – 1 – 1 –
30 8 1 8 0 8 1 3 1 8 1 7 1 8 1 8 1
34 2 0 2 – 2 – 1 – 1 – 2 – 2 – 2 –
45 8 1 8 0 7 0 4 0 5 1 7 1 7 0 8 0
81 2 0 2 – 2 – 1 – 1 – 2 – 2 – 2 –
97 7 0 7 – 6 – 6 – 6 – 7 – 6 – 7 –
101 1 0 1 – 1 – 1 – 1 – 1 – 1 – 1 –
105 0 2 – 2 – 0 – 0 – 0 – 2 – 2 – 2
109 3 0 3 – 3 – 0 – 3 – 3 – 3 – 3 –
121 6 0 5 – 4 – 4 – 4 – 6 – 5 – 6 –
239 0 10 – 1 – 0 – 0 – 0 – – – 4 – 0
241 1 0 1 – 1 – 0 – 1 – 0 – 1 – 1 –
247 1 0 1 – 0 – 1 – 1 – 1 – 1 – 1 –
398 1 0 1 – 1 – 1 – 1 – 0 – 1 – 1 –
N.D. 4 0 4 – 4 – 3 – 3 – 3 – 3 – 4 –
Total of
isolates (%)
70 (53%) 62 (47%) 66 (94.3%) 46 (74.1%) 65 (92.9%) 43 (69.3%) 43 (61.4%) 39 (62.9%) 60 (85.7%) 47 (75.8%) 61 (87.1%) 51 (82.3%) 66 (94.3%) 54 (87.1%) 70 (100%) 45 (72.6%)
530  b r a z j i n f e c t d i s . 2 0
Fig. 1 – UPGMA dendrogram. The color code reﬂects MLVA
clusters when using the 45% cutoff. ID: strain identiﬁcation.
PVL*: identiﬁcation of PVL haplotype in selected isolates.
MG:  MLVA genotype. PS: population set. 1 6;2  0(6):525–533
predominance of this clone in Ecuador.16 These isolates form a
deﬁned cluster in both UPGMA and MST analysis. The related
clone was originally identiﬁed in the USA in 2000 after causing
skin and soft issue infections in football players in Pennsyl-
vania and prisoners in Missouri. At that time, USA300 was
the most prevalent CA-MRSA clone isolated.15 We identiﬁed
USA300 related isolates in P1, P2 and P3, demonstrating that
this clone was already circulating in Ecuador as early as 2005.
The ﬁrst reports of this clone in the northern South America
region came from Colombia, also in 2005.35 The ST8-MRSA-
IV, PVL negative isolates found in this study could be related
to Lyon Clone/UK-EMRSA-2, frequently isolated in France; UK-
EMRSA-6, or USA500, identiﬁed in the USA, Australia, the UK,
Ireland, and Sub-Saharan Africa.6 It is an interesting highlight
that the presence of the PVL virulence factor was linked to ST8
related isolates; only eight isolates from different STs were PVL
positive. Moreover, the sequence of the lukS-PV and lukF-PV
genes of the 16 ST8-MRSA-IV-PVL positive isolates analyzed
here identiﬁed the haplotype R in all of them. The PVL haplo-
type R is strongly related to MRSA strains especially those of
ST8 lineage.17,29 The ST8 related isolates represent 70.97% of
the MRSA isolates found in this study, underscoring the suc-
cess of this ST in the region.11,12,16,18,35,36 Moreover, many  of
the isolates related to ST8 showed susceptibility to all antibi-
otics tested in this work. This extensive susceptibility proﬁle is
described as characteristic to USA300 clone strains.15 Only 10
of the ST8 isolates were resistant to erythromycin, gentamicin,
ciproﬂoxacin, or trimethoprim-sulfamethoxazole.
Previously, we had identiﬁed the Brazilian clone as the most
prevalent HA-MRSA clone in Ecuador.16 Here, we detected
10 isolates related to this clone (ST239-MRSA-III), the second
most prevalent ST found in this study. The ST239 clonal group,
recognized as one of the oldest pandemic MRSA strains, is
the result of a chromosomal recombination event involving
parental ST8 and ST30 strains.6,37,38 The ST239 clonal group
has been reported worldwide and it is divided into three
clades, I, II and III.37 The Brazilian clone, belonging to clade
III, was reported in early 1990s in Brazil and is now identiﬁed
in virtually the entire region.6,9,37,39 Here, we  identiﬁed isolates
related to the ST239 clone in samples from 2005, 2009, 2010,
2012, and 2013. The random choice of samples did not allow
us to estimate the real prevalence of ST239, but this analysis
of samples taken over several years did give us an idea of the
timing of the presence of this clone in Ecuador. Additionally,
these ST239 isolates have a typical resistance proﬁle reported
for this clone: ciproﬂoxacin, erythromycin, clindamycin, and
trimethoprim-sulfamethoxazole resistance.9
There is no record of isolates related to CC5 in Ecuador. In
this study, we identiﬁed three isolates related to CC5 MRSA
pandemic clones: two isolates related to the New York/Japan
clone (ST5-MRSA-II) and one isolate related to the Pedi-
atric clone (ST5-MRSA-IV). The New York/Japan clone was
described in the mid-1990s as the MRSA strain most prevalent
in New York metropolitan hospitals. Later studies demon-
strated that this clone was dominant in Japan in the early
1990s, showing the transcontinental spread of the clone.40 The
New York/Japan clone has been described in the USA, the UK,
Portugal, Germany, and other European countries. It has also
been described in Asia, speciﬁcally China and Taiwan, and
in Australia.6 In South America, this clone was detected in
b r a z j i n f e c t d i s . 2 0 1 6;2 0(6):525–533 531
Fig. 2 – Minimum spanning tree of the 132 S. aureus isolates. It represents the relationship of all isolates analyzed in this
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ctudy. The different sequence types (ST) identiﬁed are repres
razil,9 but not in neighboring countries, such as Colombia
nd Peru. These two isolates, related to the New York/Japan
lone, were recovered from P1, in 2012 and 2013 at the same
ospital, but their sporadic occurrence suggests that these two
T5-MRSA-II isolates are not related. On the other hand, the
ne isolate related to the Pediatric clone (ST5-MRSA-IV) was
etected in P3, from 2006, suggesting the displacement of this
lone.
The UK-EMRSA-15 clone (ST22-MRSA-IV) is the most preva-
ent HA-MRSA clone in some regions of Europe (UK, Portugal
nd Ireland) and Singapore.1,6,41 In South America the ST22-
RSA-IV proﬁle was only recorded from one isolate from
enezuela.16 We  found one isolate with the UK-EMRSA-15
roﬁle, probably representing the second record of this clone
n South America. Another important clone found in this
tudy was ST45-MRSA-II, known as the USA600 clone. This
lone appears to be largely restricted to North America, with
poradic reports from Hong Kong and Australia.6 In South
merica it has been recorded in Uruguay.9
The principal MSSA isolates identiﬁed were ST5, ST8, ST22,
T30, ST45, and ST97. Some MSSA strains are the ancestral
trains of epidemic MRSA clones, such as ST30 MSSA, which
volved into the Southwest Paciﬁc Clone (USA1100).42,43 We
ound several isolates to have the same ST background as
RSA epidemic clones, including ST8-MSSA, ST5-MSSA, and
T22-MSSA. Because numerous studies have demonstrated
hat some pandemic MRSA clones could have been originated
hrough intermittent events of acquisition and loss of SCCmec,
urveillance of MSSA isolates is important.5,42Only one isolate each of ST5-MRSA-IV, ST22-MRSA-IV and
T45-MRSA-II was found, and could be cataloged as imported
ases or furtive events of SCCmec cassette acquisition.d in different colors. CC, clonal complex.
In South America, LA-MRSA ST398 was reported in Brazil
and Peru, associated with cows and pigs, respectively.44,45 In
the other hand, LA-MSSA ST398 had been previously described
in Colombia as causing infection in a woman without live-
stock association.46 Here, we found a MSSA isolate, recovered
from a blood stream infection (P1), related to the livestock
associated clone ST398. MSSA isolates of this clone have
been recovered from blood stream infections and suggested
as a human adapted sub-clone.22 However, further investiga-
tions theorize LA-MRSA/MSSA ST398 clone has human origin
as MSSA lineage, which spread into farm animals where it
acquired methicillin and tetracycline resistance.20,47 Most of
the reports describing ST398 strains isolated from infection
in humans without risk factors (livestock contact) are MSSA
type and tetracycline susceptible, differing from tetracycline-
resistant strains recovered from livestock.21,22,47 Although, our
isolate came from a patient without known previous ani-
mal  contact, the tetracycline resistance suggests an animal
origin.
In conclusion, we detected a wide variety of STs in
both MRSA and MSSA. We identiﬁed the presence of pre-
viously undetected clones in Ecuador, as well as conﬁrmed
the prevalence of clones that had already been reported
in the region, which was made feasible because of the
type of sampling that we  applied in this study. Our  results
emphasize the need for a deep analysis of the current
epidemic structure of S. aureus to accomplish a more  accu-
rate surveillance. Additionally, because of the low cost and
powerful discriminatory power of the MLVA 14Orsay geno-
typing approach, we were able to successfully apply this
tool to identify the circulating clones of S. aureus in Quito,
Ecuador.
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